Literature DB >> 11872367

Impact of insulin resistance on neointimal tissue proliferation after coronary stent implantation. Intravascular ultrasound studies.

Tsutomu Takagi1, Takashi Akasaka, Atsushi Yamamuro, Yasuhiro Honda, Takeshi Hozumi, Shigefumi Morioka, Kiyoshi Yoshida.   

Abstract

Serial intravascular ultrasound (IVUS) studies in 55 nondiabetic patients showed that neointimal tissue proliferation after stent implantation in patients with impaired glucose tolerance (IGT) was greater than that in patients with normal glucose tolerance at follow-up. Multiple regression analysis showed that the sum of insulin levels was the best predictor of the greater neointimal index at follow-up. Another group of serial IVUS studies were performed in 62 stented lesions in 52 patients with Type 2 diabetes mellitus (DM). The study patients were randomized into a troglitazone group and a control group. The neointimal tissue proliferation at follow-up in the troglitazone group was significantly smaller than that in the control group.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872367     DOI: 10.1016/s1056-8727(01)00190-8

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  8 in total

Review 1.  Percutaneous coronary intervention in diabetics.

Authors:  Juhana Karha; Deepak L Bhatt
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

Review 2.  C-Peptide in insulin resistance and vascular complications: teaching an old dog new tricks.

Authors:  Dennis Bruemmer
Journal:  Circ Res       Date:  2006-11-24       Impact factor: 17.367

3.  Different impact of diabetes mellitus on in-hospital and 1-year mortality in patients with acute myocardial infarction who underwent successful percutaneous coronary intervention: results from the Korean Acute Myocardial Infarction Registry.

Authors:  Keun-Ho Park; Youngkeun Ahn; Myung Ho Jeong; Shung Chull Chae; Seung Ho Hur; Young Jo Kim; In Whan Seong; Jei Keon Chae; Taek Jong Hong; Myeong Chan Cho; Jang Ho Bae; Seung Woon Rha; Yang Soo Jang
Journal:  Korean J Intern Med       Date:  2012-05-31       Impact factor: 2.884

Review 4.  Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.

Authors:  Giovanni Anfossi; Isabella Russo; Gabriella Doronzo; Alice Pomero; Mariella Trovati
Journal:  Mediators Inflamm       Date:  2010-06-28       Impact factor: 4.711

5.  The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction.

Authors:  Bernard R Chaitman; Regina M Hardison; Dale Adler; Suzanne Gebhart; Mary Grogan; Salvador Ocampo; George Sopko; Jose A Ramires; David Schneider; Robert L Frye
Journal:  Circulation       Date:  2009-11-17       Impact factor: 29.690

6.  Effect of Pioglitazone in Preventing In-Stent Restenosis after Percutaneous Coronary Intervention in Patients with Type 2 Diabetes: A Meta-Analysis.

Authors:  Shi-Jie Zhao; Zhao-Shuang Zhong; Guo-Xian Qi; Li-Ye Shi; Ling Chen; Wen Tian
Journal:  PLoS One       Date:  2016-05-10       Impact factor: 3.240

7.  Insulin resistance and dysglycemia are associated with left ventricular remodeling after myocardial infarction in non-diabetic patients.

Authors:  Chen Die Yang; Ying Shen; Lin Lu; Feng Hua Ding; Zhen Kun Yang; Rui Yan Zhang; Wei Feng Shen; Wei Jin; Xiao Qun Wang
Journal:  Cardiovasc Diabetol       Date:  2019-08-07       Impact factor: 9.951

8.  Transcriptional Control of Vascular Smooth Muscle Cell Proliferation by Peroxisome Proliferator-Activated Receptor-gamma: Therapeutic Implications for Cardiovascular Diseases.

Authors:  Florence Gizard; Dennis Bruemmer
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.